av/argenx--big.svg

COM:ARGENX

argenx

  • Stock

EUR

Last Close

582.60

25/11 09:24

Market Cap

25.12B

Beta: -

Volume Today

4.76K

Avg: -

  • name

    argenx SE
  • homepage url

    www.argenx.com
  • country

    NLNetherlands
  • employee count

    1,148
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    1.20B
  • monthly webtraffic

    29.27K
  • monthly webtraffic growth

    59.07%
  • raised capital

    1.10B

Description

argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelin...Show More

peer of

competitor of